Satisfying the needs of Japanese cancer patients: A comparative study of detailed and standard informed consent documents

Clinical Trials

Volumn 11, Issue 1, 2014, Pages 86-95

  Sato, Keiko ^a   Watanabe, Toru ^b   Katsumata, Noriyuki ^c   Sato, Tosiya ^d   Ohashi, Yasuo ^e  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Hamamatsu Oncology Center   (Japan)

^c NIPPON MEDICAL SCHOOL MUSASHI KOSUGI HOSPITAL   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANXIETY; BREAST NEOPLASMS; COMPREHENSION; CONSENT FORMS; FEMALE; HUMANS; INFORMED CONSENT; JAPAN; MIDDLE AGED; PATIENT SATISFACTION; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84893904587     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1177/1740774513515550     Document Type: Article

References (60)

1. Levine RJ Ethics and Regulation of Clinical Research. 2 nd edn). Vurland and Schwarzenburg, Baltimore, MD, 1987, pp. 95-153. Levine RJ, ed. Baltimore, MD: Vurland and Schwarzenburg ; 1987: 95-153.
2. Berg JW, Appelbaum PS, Lidz CW, Parker LS Informed Consent: Legal Theory and Clinical Practice. 2 nd edn). Oxford University Press, New York, 2001, pp. 249-303. Berg JW Appelbaum PS Lidz CW Parker LS, ed. New York: Oxford University Press ; 2001: 249-303.
3. Leflar RB. Informed consent and patients' rights in Japan. Houst Law Rev. 1996 ; 33: 74-96
4. Kubo A, Nakagawa K, Miyamoto Y, et al. Informed consent in the therapy of lung cancer patients. J Jpn Soc Cancer Ther. 1995 ; 30: 664-79
5. Ueda K. Present status of compliance with GCP (Part3)-Results of questionnaire to investigators. Clin Eval. 1996 ; 24: 57-87
6. Drug Registration Requirements in Japan. 5 th edn). Yakuji Nippo, Tokyo, Japan, 1993 (in Japanese). Tokyo, Japan: Yakuji Nippo ; 1993 :
7. Japan's New GCP and Other Rules on Clinical Trials. Tokyo, Japan: Yakuji Nippo ; 1998 :
8. Long SO, Long BD. Curable cancer, ulcers fatal. Attitude toward cancer in Japan. Soc Sci Med. 1982 ; 16: 2101-08
9. Tazawa H, Nakajima H, Ishihara J, et al. Informed consent in patients with lung cancer: Based on the questionnaire in Japan. J Jpn Soc Cancer Ther. 1986 ; 21: 2454-59
10. Hatarakizakari no gan shi. Tokyo, Japan: Nankodo Co. Ltd ; 1994: 145-76.
11. Elwyn TE, Fetters MD, Gorenflo DW, et al. Cancer disclosure in Japan: Historical comparisons, current practices. Soc Sci Med. 1998 ; 46: 1151-63
12. Tazawa H, Satoh I, Ishihara J, et al. Informed consent of the family in the chemotherapy for lung cancer. J Jpn Soc Cancer Ther. 1990 ; 25: 1448-53
13. Watanabe T, Sano M, Takashima S, et al. Oral uracil and tegafur compared with classic cyclophosphamide, methotrexate, fluorouracil as postoperative chemotherapy in patients with node-negative, high-risk breast cancer: National Surgical Adjuvant Study for Breast Cancer 01 Trial. J Clin Oncol. 2009 ; 27: 1368-74
14. International Conference on Harmonisation of Technical Requirement for Registration of Pharmaceuticals for Human use. ICH Harmonised Tripartite Guideline: Guideline for Good Clinical Practice E6 (R1). 1997. Available at: http://www.ich.org/fileadmin/Public-Web-Site/ICH-Products/Guidelines/Efficacy/ E6-R1/Step4/E6-R1--Guideline.pdf (accessed 6 March 2013).
15. Morrow GR. How readable are subject consent forms?. JAMA. 1980 ; 244: 56-80
16. LoVerde ME, Prochazka AV, Byyny RL. Research consent forms: Continued unreadability and increasing length. J Gen Intern Med. 1989 ; 4: 410-12
17. Ogloff JR, Otto RK. Are research participants truly informed? Readability of informed consent forms used in research. Ethics Behav. 1991 ; 1: 239-52
18. Meade CD, Howser DM. Consent forms: How to determine and improve their readability. Oncol Nurs Forum. 1992 ; 19: 1523-28
19. Grossman SA, Piantadosi S, Covahey C. Are informed consent forms that describe clinical oncology research protocols readability by most patients and their families?. J Clin Oncol. 1994 ; 12: 2211-15
20. Goldstein AO, Frasier P, Curtis P, Reid A, Kreher NE. Consent form readability in university-sponsored research. J Fam Pract. 1996 ; 42: 606-11
21. Sharp SM. Consent documents for oncology trials. Does anybody read these things?. Am J Clin Oncol. 2004 ; 27: 570-75
22. Taub HA, Baker MT, Sturr JF. Informed consent for research. Effects of readability, patient age, and education. J Am Geriatr Soc. 1986 ; 34: 601-06
23. Rogers CG, Tyson JE, Kennedy K, et al. Conventional consent with opting in versus simplified consent with opting out: An exploratory trial for studies that do not increase patient risk. J Pediatr. 1998 ; 132: 606-11
24. Davis TC, Holcombe RF, Berkel HJ, et al. Informed consent for clinical trials: A comparative study of standard versus simplified forms. J Natl Cancer Inst. 1998 ; 90: 668-74
25. Bjorn E, Rossel P, Holm S. Can the written information to research subjects be improved: An empirical study. J Med Ethics. 1999 ; 25: 263-67
26. Coyne CA, Xu R, Raich P, et al. Randomized, controlled trial of an easy-to-read informed consent statement for clinical trial participation: A study of the Eastern Cooperative Oncology Group. J Clin Oncol. 2003 ; 21: 836-42
27. Asianinfo.org. Japanese education and literacy. Available at: www.asianinfo.org/asianinfo/japan/pro-education.htm (accessed 6 March 2013).
28. Shinoda Y Communication Skills. Tokyo, Japan: Chuokoron-Shinsha ; 1986 :
29. Doak LG, Doak CC, Meade CD. Strategies to improve cancer education materials. Oncol Nurs Forum. 1996 ; 23: 1305-12
30. Howard JM, DeMets D. How informed is informed consent? The BHAT experience. Control Clin Trials. 1981 ; 2: 287-303
31. Lynoe N, Sandlund M, Dahlqvist G, et al. Informed consent: Study of quality of information given to participants in a clinical trial. BMJ. 1991 ; 303: 610-13
32. Van Stuijvenberg M, Suur MH, de Vos S, et al. Informed consent, parental awareness, and reasons for participating in a randomized controlled study. Arch Dis Child. 1998 ; 79: 120-25
33. Featherstone K, Donovan JD. 'Why don't they just tell me straight, why allocate it?' The struggle to make sense of participating in a randomized controlled trial. Soc Sci Med. 2002 ; 55: 709-19
34. Kodish E, Eder M, Noll RB, et al. Communication of randomization in childhood leukemia trials. JAMA. 2004 ; 291: 470-75
35. Robinson EJ, Kerr CE, Stevens AJ, et al. Lay public's understanding of equipoise and randomisation in randomized controlled trials. Health Technol Assess. 2005 ; 9: 1-192
36. Mijika na iryo yoron chosa. Asahi Shimbun. 2000 ;:
37. Kokusai-hikaku kyoiku joho soran. Japan: Chuo-hoki, Tokyo ; 1980 :
38. Peterson BT, Clancy SJ, Champion K, et al. Improving readability of consent forms: What the computers may not tell you. IRB. 1992 ; 14: 6-8
39. Flory J, Emanuel E. Interventions to improve research participants' understanding in informed consent for research: A systematic review. JAMA. 2004 ; 292: 1593-601
40. Denning S The Leader's Guide to Storytelling. San Francisco, CA: Jossey-Bass, A Wiley Imprint ; 2005 :
41. Enama ME, Hu Z, Gordon I, et al. Randomization to standard and concise informed consent forms: Development of evidence-based consent practice. Contemp Clin Trials. 2012 ; 33: 895-902
42. Natsume F. Japan's manga culture. Jpn Found Newsl. 2000 ; 27: 1-6
43. Ministry of Education. Japanese Government Policies in Education, Science, Sports and Culture2000 (in Japanese). Available at: http://www.mext.go.jp/b-menu/hakusho/html/hpae200001/hpae200001-2-079.html (accessed 6 March 2013).
44. Houts PS, Doak CC, Doak GD, et al. The role of pictures in improvement health communication: A review of research on attention, comprehension, recall and adherence. Patient Edu Couns. 2006 ; 61: 173-90
45. Miller S, Le PV, Craig S, et al. How to make consent informed: Possible lessons from Tibet. IRB. 2007 ; 29: 7-14
46. Simes RJ, Tattersall MH, Coates AS. Randomised comparison of procedures for obtaining informed consent in clinical trials of treatment for cancer. BMJ. 1986 ; 293: 1065-68
47. BarroRJLeeJW. International data on educational attainment updates and implications. Available at: http://scholar.harvard.edu/files/barro/files/educ- attainment-updates-2000.pdf (accessed 6 March 2013).
48. Meade CD, Byrd JC. Patients literacy and the readability of smoking education literature. Am J Public Health. 1989 ; 79: 204-06
49. Davis TC, Bocchini JA, Fredrickson D, et al. Parent comprehension of polio vaccine information pamphlets. Pediatrics. 1996 ; 97: 804-10
50. Murphy DA, O'Keefe ZH, Kaufman AH. Improving comprehension and recall of information for an HIV vaccine trial among women at risk for HIV: Reading level simplification and inclusion of picture to illustrate key concepts. AIDS Educ Prev. 1999 ; 11: 389-99
51. Pace C, Talisuna A, Wendler D, et al. Quality of parental consent in a Ugandan malaria study. Am J Public Health. 2005 ; 95: 1184-89
52. Yamadori A Wakaru toha doiu kotoka: Ninshiki no No-kagaku. Tokyo, Japan: Chikuma Shobo ; 2002 :
53. Cahana A, Hurst SA. Voluntary informed consent in research and clinical care: An update. Pain Pract. 2008 ; 8: 446-51
54. Fitzgerald DW, Marotte C, Verdier RI, et al. Comprehension during informed consent in a less-developed country. Lancet. 2002 ; 360: 1301-02
55. Flory JH, Wendler D, Emanuel EJ The Oxford Textbook of Clinical Research Ethics. Emanuel EJ Grady C Crouch RA, ed. New York: Oxford University Press, Inc. ; 2008: 645-60.
56. Inoue T, Fujita T, Kishimoto H, et al. Randomized controlled study on the prevention of osteoporotic fractures (OF study): A phase IV clinical study of 15-mg menatetrenone capsules. J Bone Miner Metab. 2009 ; 27: 66-75
57. Sato K. Yoku-wakaru setsumeibunsho no tsukurikata [How to develop a easy-to-understand consent document]. Jpn Pharmacol Ther. 2002 ; 30: 283-87
58. Sato K Textbook of Clinical Trials: Design, Conduct, Analysis and Reporting. Ohashi Y Arakawa Y, ed. Tokyo, Japan: Nankodo Co., Ltd ; 2006: 99-105.
59. Beardsley E, Jefford M, Mileshkin L. Longer consent forms for clinical trials compromise patient understanding: So why are they lengthening?. J Clin Oncol. 2007 ; 25: e13-14
60. Berger O, Gronberg BH, Sand K, et al. The length of consent documents in oncological trials is doubled in twenty years. Ann Oncol. 2009 ; 20: 379-85